X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4241) 4241
Newsletter (754) 754
Publication (573) 573
Newspaper Article (75) 75
Book Review (58) 58
Book Chapter (20) 20
Transcript (15) 15
Magazine Article (12) 12
Conference Proceeding (9) 9
Trade Publication Article (5) 5
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ipilimumab (4677) 4677
immunotherapy (2738) 2738
index medicus (2570) 2570
melanoma (2393) 2393
humans (2330) 2330
oncology (2278) 2278
cancer (1834) 1834
nivolumab (1332) 1332
care and treatment (1301) 1301
metastasis (1052) 1052
male (1030) 1030
melanoma - drug therapy (998) 998
metastatic melanoma (988) 988
antibodies, monoclonal - therapeutic use (923) 923
female (910) 910
research (879) 879
pembrolizumab (841) 841
middle aged (821) 821
immunology (733) 733
chemotherapy (707) 707
survival (704) 704
aged (694) 694
drug therapy (645) 645
open-label (599) 599
antibodies, monoclonal - adverse effects (569) 569
antineoplastic agents - therapeutic use (562) 562
treatment outcome (551) 551
patients (530) 530
melanoma - pathology (527) 527
adult (521) 521
tumors (503) 503
skin neoplasms - drug therapy (500) 500
therapy (499) 499
safety (477) 477
immunotherapy - methods (469) 469
clinical trials (438) 438
pd-1 (432) 432
analysis (431) 431
cancer therapies (423) 423
ctla-4 (399) 399
medical research (389) 389
blockade (387) 387
immune checkpoint (377) 377
lymphocytes (376) 376
melanoma - immunology (369) 369
advanced melanoma (366) 366
skin neoplasms - pathology (364) 364
adverse events (356) 356
health aspects (349) 349
t cells (343) 343
aged, 80 and over (338) 338
animals (332) 332
programmed cell death 1 receptor - antagonists & inhibitors (331) 331
medicine, research & experimental (330) 330
medicine & public health (326) 326
antineoplastic agents - adverse effects (325) 325
apoptosis (325) 325
complications and side effects (322) 322
prognosis (314) 314
dermatology (313) 313
antigens (304) 304
ctla-4 antigen - antagonists & inhibitors (303) 303
lung cancer (303) 303
antibodies, monoclonal - administration & dosage (301) 301
melanoma - therapy (300) 300
vemurafenib (299) 299
metastases (298) 298
article (284) 284
multicenter (275) 275
antibodies (272) 272
medicine, experimental (272) 272
melanoma - secondary (272) 272
usage (272) 272
t-cells (269) 269
monoclonal antibodies (268) 268
double-blind (263) 263
mutation (263) 263
cell lung-cancer (259) 259
ctla-4 blockade (256) 256
cytotoxicity (255) 255
untreated melanoma (254) 254
neoplasms. tumors. oncology. including cancer and carcinogens (252) 252
oncology, experimental (251) 251
pharmacology & pharmacy (250) 250
antibody (249) 249
expression (249) 249
ctla-4 antigen - immunology (247) 247
development and progression (246) 246
toxicity (241) 241
reports (240) 240
neoplasms - immunology (238) 238
antineoplastic combined chemotherapy protocols - therapeutic use (236) 236
trial (235) 235
biomarkers (234) 234
neoplasm staging (231) 231
immune system (228) 228
retrospective studies (228) 228
neoplasms - drug therapy (226) 226
immune checkpoint inhibitors (225) 225
melanoma - mortality (221) 221
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4920) 4920
German (72) 72
French (67) 67
Spanish (10) 10
Japanese (8) 8
Czech (6) 6
Danish (4) 4
Polish (4) 4
Russian (4) 4
Chinese (3) 3
Hungarian (2) 2
Swedish (2) 2
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Science Translational Medicine, ISSN 1946-6234, 05/2014, Volume 6, Issue 238, pp. 238ra70 - 238ra70
Journal Article
Annals of Oncology, ISSN 0923-7534, 04/2019, Volume 30, Issue 4, pp. 501 - 503
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 2, pp. 368 - 375
Journal Article